EyePoint EYPT
NASDAQ EYPT
$0.41 -0.03 (-7.58%)
As of: Oct 20, 2026 · 3:59 PM EDT

EyePoint (EYPT) Current Debt (2022 - 2023)

Updated

Analysis

EyePoint (EYPT) Current Debt (2022 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -5.75 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 64.00 Mn
10 EyePoint 35.67 Mn -877.45 Mn 507,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -5.30 Mn
Mar 31, 2023 -5.18 Mn
Mar 31, 2022 10.48 Mn
API Access

EyePoint Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=EYPT&period=max&api_key=YOUR_API_KEY